Previous Page  9 / 10 Next Page
Information
Show Menu
Previous Page 9 / 10 Next Page
Page Background

Page 33

Notes:

conferenceseries

.com

Volume 08

Journal of Alzheimers Disease & Parkinsonism

Alzheimer's Congress 2018

May 30-31, 2018

May 30-31, 2018 Osaka, Japan

10

th

World Congress on

Alzheimer's Disease & Dementia

Neuronal excitability changes produced by alzheimer’s related pathology and by its risk factors

Herman Moreno, Luna Buitrago and Sergio Angulo

SUNY Downstate Medical Center, USA

A

lzheimer’sDisease (AD) is characterized by synaptic dysfunction early in the progression of the disease. It remains unknown

the specific neuronal abnormalities produced by AD related pathology (Amyloid and Tau) to the Entorhinal Cortex (EC)-

hippocampus circuit, the region targeted earliest by AD. Here, we address this issue by studying mice that express mutated

human Amyloid Precursor Protein (hAPP) or mutated human Tau protein (hTau) or both in the EC. This approach allowed us

to investigate the two pathologies separately and together additionally we also studied mice expressing the main genetic risk

factor for AD (APOE4). Mice (APOE4) were compared to those expressing APOE3. The experiments showed that expression

of mutant hAPP in EC (EC-hAPP) produced a significant increase in the duration of spontaneous extracellular field potentials

in the superficial layers of both Medial EC and Lateral EC. We also observed that in EC-hAPP mice, pyramidal neurons of the

subiculum, which are monosynaptically excited by EC layer III/II neurons, showed miniature excitatory postsynaptic currents

having reduced amplitude, suggesting that the increased excitation observed in EC induced a compensatory negative feedback

in subicular projection neurons, a process known as synaptic homeostasis. Modeling of the EC-hippocampus microcircuits

indicates that EC hyperexcitability and subicular synaptic downscaling of mice expressing hAPP could be explained by EC

interneuron pruning. The functional changes produced in EC by the expression of mutant τ protein (P301L) manifested as

resistance to GABAA antagonist-induced hypersynchrony, but it did not, by itself, produce significant spontaneous activity

changes in EC-hippocampus circuits. Mice displaying both pathologies as early as 2.5 months of age had an intermediate and

subtler phenotype, predominantly driven by τ-pathology. An intriguing finding was the fact that mice expressing APOE4 had

a relatively similar phenotype that mice expressing hAPP. This is increased synchronous activity in LEC, but the mechanism

of such hypersynchrony is mediated by changes in GABAA receptors abnormalities in the pyramidal cell, and this is observed

late in the disease. Our findings demonstrate the significant role of the lateral and medial entorhinal cortices in the early stages

of AD where contrasting and complex interactions of APP, τ and APOE are observed.

Biography

Herman Moreno is an Associate Professor of Neurology and Pharmacology/Physiology at SUNY Downstate Medical Center, New York, USA.

herman.moreno@downstate.edu

Herman Moreno

et.al

., J Alzheimers Dis Parkinsonism 2018, Volume 8

DOI: 10.4172/2161-0460-C4-045